E

Epizyme Inc
F:EPE

Watchlist Manager
Epizyme Inc
F:EPE
Watchlist
Price: 559 EUR 3.33% Market Closed
Market Cap: 92.2B EUR

EV/FCFF
Enterprise Value to FCFF

-519.3
Current
-486.7
Median
3.7
Industry
Lower than median
Lower than industry value

Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
-519.3
=
Enterprise Value
94.2B EUR
/
FCFF
-208.9m USD
Market Cap EV/FCFF
US
Epizyme Inc
F:EPE
94.1B EUR -519.3
FR
Pharnext SCA
OTC:PNEXF
6T USD -215 985.1
US
Abbvie Inc
NYSE:ABBV
327.6B USD 25.3
US
Amgen Inc
NASDAQ:AMGN
155.7B USD 18.4
US
Gilead Sciences Inc
NASDAQ:GILD
134.5B USD 15.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.2B USD -86.8
AU
CSL Ltd
ASX:CSL
115.6B AUD 44.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
55.6B USD 16.9
US
Seagen Inc
F:SGT
39.3B EUR -62.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
40.7B USD -518.6
NL
argenx SE
XBRU:ARGX
28.7B EUR -196.7
 
US
E
Epizyme Inc
F:EPE
Average EV/FCFF: 24.1
Negative Multiple: -519.3
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -215 985.1
US
Abbvie Inc
NYSE:ABBV
25.3
US
Amgen Inc
NASDAQ:AMGN
18.4
US
Gilead Sciences Inc
NASDAQ:GILD
15.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -86.8
AU
CSL Ltd
ASX:CSL
44.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -62.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -518.6
NL
argenx SE
XBRU:ARGX
Negative Multiple: -196.7

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A